Curetis AG, a Holzgerlingen, Germany-based developer of products to diagnose severe infections, closed a €18.5m Series A Financing Round.
The round was led by an international consortium composed of four partners, including the existing investor aeris CAPITAL, which seeded Curetis with € 1.4m in 2008. New syndicate members include LSP (Life Sciences Partners), BioMedPartners and the ERP-Startfonds of the KfW Bankengruppe.
The funds will be used to enable the company to complete development of its innovative diagnostic products through to market entry.
MedVenture Partners GmbH supported Curetis in concluding the transaction.